Pharmaceutical composition for treating tumors and use
AssigneeInxmed (Nanjing) Co., Ltd.
InventorsBaoyuan Zhang, Xuebin Liu, Zaiqi Wang
Life of this patent
Estimating the term…
Abstract
The present invention relates to a combination of an FAK inhibitor, an anthracycline chemotherapeutic drug, and an immune checkpoint inhibitor to treat tumors. The present invention also relates to a combination of an FAK inhibitor and an anthracycline chemotherapeutic drug to treat tumors.
Claims23
(canceled)
(canceled)
A method of treating a tumor, comprising administering a therapeutically effective amount of an FAK inhibitor, an anthracycline chemotherapy drug and an immune checkpoint inhibitor simultaneously or sequentially to a subject in need.
A kit or a pharmaceutically acceptable composition, comprising:
- (a) an FAK inhibitor;
- (b) an anthracycline chemotherapy drug;
- and
- (c) an immune checkpoint inhibitor.
A method of enhancing immunogenic cell death induced by an anthracycline chemotherapy drug in the treatment of a tumor, wherein the method comprises administering an FAK inhibitor to a subject.
-24. (canceled)
Dependencies are inferred from the claim text.